Zeiss Vision Care Acquires Stake in Ocumeda, Maker of Tele-Ophthalmology Platform

Zeiss Vision Care announced it has signed a definitive agreement to acquire a 10% stake in Ocumeda AG from Fielmann Group for €10 million ($11.75 million), with the option to increase its holding to up to 25%. The transaction places Ocumeda’s valuation at €100 million ($117.5 million).

Ocumeda, tele-ophthalmology platform, provides digital solutions that connect opticians, optometrists, and ophthalmologists, addressing the global shortage of accessible primary eye care.

“Our investment in Ocumeda is part of our commitment to protect and improve the vision and visual health of consumers. We want to strengthen accessible eye and vision care – in Ocumeda we have found an excellent partner for this mission. A partner who shares our high standards in innovation and quality," said Sven Hermann, President and CEO of Zeiss Consumer Markets.

“We are excited to welcome Zeiss Vision Care as a strategic investor in Ocumeda. Together, we look forward to expanding Europe’s leading tele-ophthalmology platform as an open resource for patients, opticians, optometrists, and ophthalmologists. This partnership marks an important milestone in our Vision 2035 strategy to help everyone hear and see the beauty in the world," said Marc Fielmann, CEO of Fielmann Group.